Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years

Karaca, Yilmaz; Çöplü, Nilay; Gozalan, Aysegiil; Oncul, Ozgur; Çitil, Burak Ekrem; Esen, Berrin

doi:10.1016/j.ijantimicag.2005.03.012

Cited by 42 publications

(22 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Buna karşılık, TMP-SMX direnci 1996 yılında %69.3 iken, 2003 yı-lında %38.5'a düşmüştür. Bu değişimin nedeni, ampirik tedavide kinolonların ilk tercih olarak kullanılması ve TMP-SMX kullanımı-nın azalması olarak belirtilmiştir (8). Manisa'da yapılan bir çalış-mada, ampirik ampisilin ve TMP-SMX başlanmasının, ÜSE'lerin yaklaşık yarısında yeterli olmadığı gösterilmiştir (9).…”

Section: Discussionunclassified

Antibiotic Susceptibility of Escherichia coli Strains Isolated in Community Acquired Urinary Tract Infections

Gözüküçük¹,

Çakıroğlu²,

Nas³

2012

JAREM

View full text Add to dashboard Cite

ÖZETAmaç: Bu çalışmada, İstanbul'da bir özel hastanede toplum kökenli üriner sistem enfeksiyonlarından izole edilen Escherichia coli suşlarında antimikrobiyal duyarlılıklarının belirlenmesi amaçlanmıştır. Results: A total of 191 E. coli strains isolated from urine cultures which were processed between January 2008 and December 2008 in the clinical laboratory, were included in the study. Identification of bacteria and antibiotic susceptibility tests were performed by disk diffusion and automated system. Of E. coli strains, 14.6% (n=28) were found positive for ESBL. The resistance rates of E. coli strains were found as follows; 12.4% for nitrofurantoin, 40% for trimethoprim/sulfamethoxazole (TMP-SMX), 19.8% for ciprofloxacin and 19.2% for ceftriaxon.Conclusion: Empirical therapy should be based on local antimicrobial resistance monitoring in order to optimize the use of these drugs. (JAREM 2012; 2: 101-3)

show abstract

Section: Discussionunclassified

Antibiotic Susceptibility of Escherichia coli Strains Isolated in Community Acquired Urinary Tract Infections

Gözüküçük¹,

Çakıroğlu²,

Nas³

2012

JAREM

View full text Add to dashboard Cite

show abstract

“…For example, in Turkey, the first-line antibiotic for UTI, trimethoprim–sulfamethoxazole (TMP–SMX), was used extensively in the early 1980s. By the early 1990s, uropathogen resistance rates to TMP–SMX had increased above 50%, leading to therapeutic failure and physicians to adopt quinolones as the preferred therapeutic for UTI [17]. In the decade following the shift toward quino-lones for UTI treatment, uropathogen resistance rates to quinolones in Turkey spiked at almost 30% [17].…”

Section: Antibiotic Therapy For Uti: Rising Resistance and Inadequate Omentioning

confidence: 99%

Preventing urinary tract infection: progress toward an effectiveEscherichia colivaccine

Brumbaugh

Mobley²

2012

Expert Review of Vaccines

176

116

View full text Add to dashboard Cite

Uncomplicated urinary tract infections (UTIs) are common, with nearly half of all women experiencing at least one UTI in their lifetime. This high frequency of infection results in huge annual economic costs, decreased workforce productivity and high patient morbidity. At least 80% of these infections are caused by uropathogenic Escherichia coli (UPEC). UPEC can reside side by side with commensal strains in the gastrointestinal tract and gain access to the bladder via colonization of the urethra. Antibiotics represent the current standard treatment for UTI; however, even after treatment, patients frequently suffer from recurrent infection with the same or different strains. In addition, successful long-term treatment has been complicated by a rise in both the number of antibiotic-resistant strains and the prevalence of antibiotic-resistance mechanisms. As a result, preventative approaches to UTI, such as vaccination, have been sought. This review summarizes recent advances in UPEC vaccine development and outlines future directions for the field.

show abstract

“…Eğer direnç artışı gösteren bir antimikrobiyal varsa öncelikli grupta olsa dahi duyarlı bulunduğunda zorunlu hâller dışında rapor etmeyerek, kullanı-mının azaltılmasına çalışılmalıdır. Bilindiği gibi kullanımın azalması zaman içinde direncin de azalması ile sonuçlanmaktadır (13) . Klinisyenlerle ortak yapılacak bir eğitim saatinde antimikrobiyal kullanımında önceliklendirme ve gruplandır-ma mantığının anlatılması ve tartışılmasında yarar vardır.…”

Section: Trimethoprim/ Sulfamethoksazoleunclassified

Approach to Surgical Wound Infections from the Perspective of Antibiotic Control Team

Çöplü¹,

Çağatay²,

Ünal³

et al. 2016

TMCD

View full text Add to dashboard Cite

show abstract

Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years

Cited by 42 publications

References 11 publications

Antibiotic Susceptibility of Escherichia coli Strains Isolated in Community Acquired Urinary Tract Infections

Antibiotic Susceptibility of Escherichia coli Strains Isolated in Community Acquired Urinary Tract Infections

Preventing urinary tract infection: progress toward an effectiveEscherichia colivaccine

Approach to Surgical Wound Infections from the Perspective of Antibiotic Control Team

Contact Info

Product

Resources

About